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Abstract
We describe an analytical method for profiling lactate production in single cells, via the use of 
coupled enzyme reactions on surface-grafted resazurin molecules. The immobilization of the 
redox-labile probes was achieved through chemical modifications on resazurin, followed by bio-
orthogonal click reactions. The lactate detection scheme was demonstrated to be sensitive and 
specific. The method was incorporated into the single cell barcode chip platform for simultaneous 
quantification of aerobic glycolysis activities and oncogenic signaling phosphoproteins in cancer. 
We interrogated the interplay between glycolysis and oncogenic signaling activities on a 
glioblastoma cell line. Results revealed a drug-induced oncogenic signaling reliance 
accompanying shifted metabolic paradigms. A drug combination that exploits this induced 
reliance exhibited synergistic effects in growth inhibition.
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The upregulation of aerobic glycolysis, known as the Warburg effect, is a hallmark of many 
cancers.[1] A common paradigm is that the driver oncogenic signaling confers and maintains 
the elevated glycolytic activities;[2] however, recent studies have revealed that metabolic 
processes, such as aerobic glycolysis, are also capable of actively modulating cell-signaling 
networks.[3] Those results highlight the complex interactions that exist between aerobic 
glycolysis and oncogenic signaling. Efforts in deciphering such interactions can be 
confounded by the intra- and inter-tumoral heterogeneity – a common feature of all cancers. 
Such heterogeneity facilitates tumor cells to adapt to stress through adopting new signaling 
and metabolic paradigms.[4]
Single cell assays hold the promise to unveil the heterogeneity as well as the interplay 
between metabolic and oncogenic signaling, informing the rational design of therapeutic 
strategies that target tumor vulnerabilities. To this end, we have recently developed 
integrated proteomic and metabolic single cell assays on the single cell barcode chip 
(SCBC) platform, where glucose influx and signaling protein activities were simultaneously 
quantified from individual cells with fluorescence readouts.[5] However, glucose influx 
provides only an incomplete view of aerobic glycolytic capabilities,[1c, 6] because the 
metabolic fate of the consumed glucose is not resolved. This caveat is especially prominent 
under drug perturbations, where subpopulations of cells may alter their glucose utilization to 
tolerate the drug stress.[5, 7] Thus, quantifications of both glucose influx and lactate 
production at the single-cell level is required for a comprehensive understanding of the 
aerobic glycolysis in heterogeneous tumors.
In addition, there is an ever-increasing interest in further deciphering how the interplays 
between the Warburg effect and the oncogenic signaling provide a metabolic advantage to 
cancer cells, thereby promoting tumor growth. [8] With the aim of untangling the 
mechanistic links among those components in heterogeneous tumors, it is necessary to 
perform simultaneous measurements on a panel of oncogenic signaling phosphoproteins, 
glucose influx and lactate production at the single cell level. To date, such task is only 
possible through the SCBC technology. Therefore, an orthogonal chemical approach that 
translates lactate quantity to fluorescence readouts so as to be incorporated into the SCBC 
platform is a pressing need.
Currently, quantification of lactate at the single cell level remains challenging. A major 
obstacle is the secretion nature of lactate, which renders those well-established uptake-based 
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detection schemes incompatible. Another challenge is the lack of lactate-specific antibodies, 
due to their extremely small size and endogenous existence. Therefore, it is impractical to 
develop immuno-based lactate detection methods.
Herein, we report on a chemical method for quantifying lactate production from single cells 
using a surface-immobilized redox-labile fluorescent probe and coupled enzyme reactions 
(Figure 1a). This approach was designed to be compatible with our previously reported 
SCBC platform (Figure 1b).[5] By integrating the quantitation of lactate production with 
glucose influx, as well as assays for key elements of the epidermal growth factor receptor 
(EGFR) signaling pathway, we were able to interrogate a glycolysis-addicted patient-derived 
EGFR variant III (EGFRvIII) mutant glioblastoma neurosphere model (GBM39) under 
different therapeutic perturbations. We resolved the aerobic glycolysis activity and its 
interplay with the oncogenic signaling at the single-cell level.
The lactate detection in this study was based on the surface-immobilized resazurin/resorufin 
as the fluorescence reporter (Figure 1a). The resazurin/resorufin pair has been widely 
employed in various analytical methods for redox-active metabolites due to its fast reaction 
kinetics and prominent fluorescence spectra changes in detecting NADH – a common 
mediator of enzymatic redox processes.[9] However, those studies were exclusively carried 
out in bulk solutions. To the best of our knowledge, there is no report of incorporating this 
redox pair for surface-based biosensor construction. This is probably due to the challenges 
in immobilizing resazurin, whose redox lability could lead to insufficient probe stability and 
poor assay sensitivity.
As the starting point for attempting resazurin immobilization, we first synthesized 4-
carboxyresazurin (CRz) to enable further conjugation. Other modifications to resazurin, such 
as the alkylation and acetylation on the phenolic hydroxyl group, render the resulting 
resorufin counterparts non-fluorescent. A closer investigation revealed that the CRz adopted 
the salicylic acid structure as the preferred configuration (Figure 2, Supporting information 
Figure S1). Although both isomers demonstrated negative electrostatic potentials on the 
carboxyl groups, the salicylic form exhibited a weaker and more dispersed potential. In 
addition, the highest occupied molecular orbital (HOMO) for the salicylic form involved no 
contribution from the carboxyl group. In comparison, the carboxyl-quinone isomer had a 
more carboxyl-centric HOMO. All these factors contribute to the strongly compromised 
reactivity of the carboxyl group. As a result, direct conjugation of CRz to the surface led to 
negligible yield. In order to improve the CRz reactivity, we converted the aromatic 
carboxylic group to aliphatic reactive groups. Four types of extended CRz structures bearing 
amine, carboxyl, biotin and azide functional groups were successfully synthesized at 
appreciable quantities (Supporting information Figure S2-S5). These functional groups 
provided the basis for surface immobilization reactions.
In order to be adapted to the SCBC platform, the probe immobilization process should be 
compatible with the single-stand DNA hybridization process.[5] However, the N-oxide group 
on CRz confers strong redox lability. Consequently, the attempt of conjugating the amine-
modified CRz to a single strand DNA (ssDNA) was unsuccessful. Likewise, ssDNA coupled 
to carboxyl-modified CRz suffered from spontaneous reduction. On the contrary, both the 
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biotin-modified CRz (BRz) and azide-modified CRz (APRz) demonstrated superior stability 
(Supporting information Figure S6, S7).
We then evaluated the BRz and APRz probes for their performance in lactate detection 
experiments. BRz was immobilized onto the surface through ssDNA-streptavidin 
conjugates. Similarly, dibenzocyclooctyne-modified ssDNA enabled surface grafting of 
APRz molecules (Figure 3a).[10] The resazurin-modified surfaces were exposed to a solution 
containing a mixture of sodium lactate, nicotinamide adenine dinucleotide (NAD+), lactate 
dehydrogenase (LDH) and diaphorase. In this case, the enzyme reaction cascade shown in 
Figure 1a translates the lactate quantity to fluorescence readouts. As shown in Figure 3b, 
BRz exhibited unsatisfactory fluorescence increase. Further investigation revealed that the 
resorufin fluorescence was severely quenched by streptavidin (Supporting information 
Figure S8). On the other hand, APRz probes exhibited almost ten-fold increase of 
fluorescence intensity after lactate conversion (Figure 3b). More interestingly, the reduced 
APRz exhibited higher fluorescence intensity than unmodified resorufin (Supporting 
information Figure S9), possibly due to the intramolecular hydrogen bond stabilizing the 
structure. In addition, the APRz showed faster reaction kinetics in the diaphorase catalyzed 
NADH oxidation reaction than unmodified resazurin, demonstrating its superior 
performance (Supporting information Figure S10).
A potential concern of employing the enzymatic mechanism for lactate quantitation was the 
specificity of the method. The complex intracellular contents always pose strong challenges 
on such redox-based methods. In order to validate the detection scheme, we assessed the 
potential interference from common intracellular reducing agents such as glutathione and 
ascorbic acid, as well as glucose and glutamine. We found that those reductants at 
biologically-relevant levels led to insignificant fluorescence increase within the assay 
duration (Figure 3c, Supporting information Figure S11). In order to evaluate the combined 
interference from all intracellular components, we further performed validation using 
GBM39 cell lysates. Indeed, without the addition of extra NAD+, the reduction of APRz was 
negligible (Figure 3d, Supporting information Figure S12). This result was because the 
endogenous NAD(P)H level was two to three magnitudes lower than that of the lactate,[11] 
and cells constantly produced lactate. Therefore, the intracellular NAD(P)H would 
contribute only negligibly to the observed fluorescence signal. Indeed, metabolic processes 
that produce other reducing intermediates could also interfere with the lactate detection. 
However, by providing excess amount of both LDH and NAD+, the conversion of lactate 
would be significantly preferred.
We also found that the increase of fluorescence intensity corresponded well with the lactate 
concentration, both in the solution phase and on the surface (Figure 3e,f, Supporting 
information Figure S13). Particularly, the dynamic range of the surface APRz well covers 
the expected lactate concentrations at single cell level.[12] These results demonstrated that 
the APRz-based detection scheme was suitable for single cell lactate quantitation.
We then sought to adapt the lactate assay for single cell level quantitation. The surface-based 
lactate assay was incorporated onto the SCBC platform, which consisted of a two-layer 
elastomer microfluidics device coupled to a DNA barcoded glass slide.[5, 7] The device 
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contained 384 programmable microchambers where cells were loaded and lysed for 
analysis. Each microchamber was equipped with a set of DNA barcode stripes, which served 
as a scaffold for multiplex measurements (Supporting information Figure S14). We 
quantified glucose uptake, lactate production and a panel of signalling proteins from 
GBM39 single cells. GBM39 is a human glioblastoma cell line that harbours a mutated form 
of the epidermal growth factor receptor (EGFR), which drives cell proliferation. Cells were 
treated with 1 μM of erlotinib (EGFR inhibitor), 0.1 μM of oligomycin A (ATPase inhibitor) 
or DMSO (control) before analysis.
As shown in Figure 4a, erlotinib treatment dramatically decreased the glucose uptake 
capacity of GBM39 cells as well as their lactate production. Parallel measurements of 
oxygen consumption rate (OCR), extracellular acidification rate (ECAR), and lactate 
production on bulk GBM39 cells also lead to consistent results (Supporting information 
Figure S15). As a commonly used inhibitor in targeted chemotherapy, erlotinib prevents 
EGFR binding with ATP and inhibits its phosphorylation.[13] This mechanism is consistent 
with our results, where significant down regulation of the phosphorylation levels on EGFR 
as well as downstream signaling proteins. On the other hand, under the treatment of 
oligomycin, GBM39 cells exhibited a slightly higher glucose uptake, but with significantly 
increased lactate production. These results dovetailed with the functioning mechanism of 
oligomycin, which inhibited ATP synthase and blocked the cellular electron transport chain, 
leading to elevated aerobic glycolysis activities.[14] Interestingly, oligomycin also appeared 
to suppress the phosphoproteins downstream of the EGFR signaling pathway, which implied 
that change of metabolic paradigm might also affect the oncogenic signaling network.
The single cell dataset contains rich information that can be mined through statistical 
analysis. To further dissect the interplay between aerobic glycolysis and phosphoprotein 
signalling, we employed the t-distributed stochastic neighbor embedding (t-SNE) to project 
the high-dimentional single cell data into a 2D space (Supporting information Figure S16). 
We further used PhenoGraph to partition these single data into subpopulations, using a 
nearest-neighbor method.[4a, 15] We resolved 17 subpopulations (clusters) across three 
treatment conditions (Figure 4b, Supporting information Figure S16-S18). We found that 
glucose uptake level and lactate production were decoupled across many subpopulations, 
evidenced by their distribution patterns (Figure 4b, small panels). Even within the same 
sample group, the two analytes correlated poorly. For instance, cluster 1 and cluster 2 
exhibited similar glucose uptake level but drastically different lactate production. This result 
proved that glucose uptake alone could not represent aerobic glycolysis activities at single 
cell level.
We also found that the most proliferative cells from each treatment group (Clusters 5, 11 and 
17), marked by the elevated level of Ki67 (proliferation marker), exhibited rather unique 
metabolic and signalling signatures. In particular, in the control and erlotinib-treated cells, 
the proliferation ability did not correlate well with aerobic glycolysis nor the EGFR 
signalling activities (cluster 5 and 11). However, cluster 17 had the highest proliferation, 
lactate production and EGFR signalling activities within the oligomycin-treated sample 
group. Further analysis also revealed that oligomycin treatment led to strengthened 
correlations between aerobic glycolysis and oncogenic signalling, as well as within the 
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phosphoprotein signalling network (Supporting information Figure S19-S21). These results 
indicated that by promoting the highly aerobic glycolytic phenotype, oligomycin also 
reinforced the cellular reliance on oncogenic EGFR signalling. In addition, cluster 17 was 
found to be the major contributors to this increased reliance (Supporting information Figure 
S22). Given time, these cells may dominate the entire cell population based on their 
relatively higher proliferation rate. On the other hand, the elevated oncogene addiction could 
render them more susceptible to EGFR inhibition.
Based on the observations above, we hypothesized that a combination of erlotinib and 
oligomycin would induce a synergistic growth inhibition on GBM39. Indeed, such 
synergistic effect across a broad dose range of erlotinib (1–10 μM) and oligomycin (0.1–
1μM) was observed (Figure 4c, Supporting information Figure S23). In order to test the 
generality of this result, we also performed the same tests on a second EGFRvIII mutant 
GBM cell line (HK301) that is more sensitive to erlotinib treatment. As expected, we 
observed similar synergistic effects, albeit starting at lower doses of erlotinib (Supporting 
information Figure S24).
We then sought to test if the effect of oligomycin can be extended to other clinically relevant 
respiration inhibitors. We studied the therapeutic outcome of combining erlotinib with 
metformin or phenformin on GBM39 cells. The latter two drugs are approved for treating 
type-II diabetes and their reaction mechanisms are similar to that of oligomycin. Again, we 
observed significant synergistic effects (Supporting information Figure S25).
The described chemical approach for lactate quantification is complementary to our 
previously reported glucose uptake assay and enables comprehensive and true aerobic 
glycolysis profiling in single cells. When combined with the multiplex phosphoproteomic 
assays in the SCBC platform, it permits a clarifying view into how glycolytic activities relate 
to phosphoprotein signalling. It is worth pointing out that the analysis of the obtained single-
cell data requires clear knowledge of the corresponding metabolic and/or signalling 
pathways. In many cases, the interpretation of such data can be confounded by the 
complexity of biological systems, and oversimplification may lead to incorrect conclusions.
In addition to lactate detection, the surface immobilized fluorescence probes may be adapted 
to detect other redox-active metabolites, through employing different enzymatic schemes.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
a) The principle of assaying lactate through coupled enzyme reactions on resazurin 
substrates. The amount of lactate translates to the fluorescence intensity of resorufin. b) 
Surface immobilization of the resazurin analogs integrated with microfluidic-based 
technology enable the quantification of lactate production from single cells.
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Figure 2. 
Electrostatic potential and molecular orbital calculations reveal that the dominant salicylic 
isomer has compromised nucleophilicity and is unsuitable for further conjugations.
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Figure 3. 
a) Biotin-modified CRz (BRz) and azide-modified CRz (APRz) enable surface 
immobilization. b) Surface fluorescence intensities before (blue) and after (red) the lactate 
assay. Larger increase of fluorescence indicates better efficiency in lactate detection. c) 
Comparison of the fluorescence increase of APRz resulted from lactate conversion and other 
intracellular reducing agents. d) Lactate assay results using GBM39 cell lysates. APRz was 
mixed with diaphorase and LDH. To this mixture was added cell lysate, or cell lysate/NAD+. 
Background fluorescence value obtained from a lysis buffer control was subtracted. e,f) 
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Working curve for the solution phase and surface-based lactate detection, using APRz as the 
substrate. The red curves were obtained through fitting with Hill functions.
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Figure 4. 
a) Scatter plot of the single cell dataset. Red horizontal bars denote the average analyte 
levels and boxes represent the first and third quartiles of analyte distributions. Wilcoxon-
Mann-Whitney significance levels: NS, p > 0.01; **, p < 0.01; ***, p < 0.001. b) t-SNE 
projection of the PhenoGraph clusters from GBM39 single cell dataset. Each cluster is 
represented by a single circle scaled to the number of cells in that cluster. The clusters are 
either colour coded by the treatment conditions (the larger panel) or by median expression of 
indicated analytes (smaller panels).The numbers next to the circles denote the cluster name. 
c). Synergistic effects observed in erlotinib and oligomycin co-treatment experiments on 
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GBM39 cells. Red colour and positive numbers represent synergistic effects, and green 
colour with negative numbers represent antagonist effects.
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